Praj Industries Limited, established in 1983 under the leadership of Dr. Pramod Chaudhari, is a global biotechnology and engineering company. With a legacy spanning over four decades, Praj has positioned itself as a leader in providing sustainable solutions across bioenergy, high purity water systems, critical process equipment, breweries, and industrial wastewater treatment. The company operates on a farm-to-fuel model, emphasizing environmental and energy solutions. Its global footprint is extensive, with a presence in over 100 countries and more than 1000 plants installed worldwide, supported by offices in Southeast Asia and the USA. Praj's technological strength is a core pillar, demonstrated by a team of over 90 research scientists and a portfolio of more than 400 patents. The company's integrated service model, termed TEMPO (Technology, Engineering, Manufacturing, Project management, and Operations & Maintenance), ensures end-to-end project execution. This is supported by five world-class manufacturing facilities in India, strategically located near ports to facilitate global logistics. A significant portion of its business, over 40%, comes from repeat customers, underscoring its strong market reputation and client trust.

Official Website: www.praj.net

• Recent Performance (Consolidated 9M-FY26 vs 9M-FY25):

• Operating Income: Remained relatively flat, with a slight decrease of 1.9% to INR 23,233 million.

• Operating EBITDA: Saw a significant decline of 46.3% to INR 1,346 million.

• Net Profit: Experienced a sharp drop of 93.2%, falling to INR 122 million from INR 1,791 million in the prior year period.

• Diluted EPS: Consequently decreased to INR 0.67 from INR 9.74.

• Quarterly Performance (Consolidated Q3-FY26 vs Q3-FY25):

• Operating Income: Declined by 1.3% to INR 8,415 million.

• Operating EBITDA: Fell 34.9% to INR 473 million.

• Net Profit: The company reported a net loss of INR 124 million compared to a profit of INR 411 million in the same quarter last year.

• Historical Performance (Consolidated):

• The company demonstrated strong revenue growth from FY22 (INR 23,433 Mn) to FY23 (INR 35,280 Mn), before stabilizing in FY24 (INR 34,663 Mn) and seeing a decline in FY25 (INR 32,280 Mn).

• EBITDA and PAT followed a similar trend, peaking in FY24 at INR 3,879 million and INR 2,834 million, respectively.

• Return on Capital Employed (ROCE) was healthy, recorded at 23% in FY25.

• Balance Sheet Strength:

• The company is Net Debt Free, indicating a strong and unleveraged balance sheet.

• As of H1-FY26, the company held total equity of INR 13,013 million against total liabilities of INR 19,317 million.

The company's recent financial performance shows significant pressure on profitability despite stable revenues, driven by margin compression and one-time expenses. However, its historical growth and debt-free status provide a foundation of financial stability.

• Integrated "TEMPO" Model: Praj operates an end-to-end business model covering Technology, Engineering, Manufacturing, Project Management, and Operations & Maintenance. This integrated approach allows for greater control over project quality and execution.

• Strong R&D and Intellectual Property: The company has a robust R&D focus with a team of over 90 scientists and more than 400 patents filed. This commitment to innovation secures its technological edge in the industrial biotechnology space.

• High Customer Retention: Over 40% of the company's business is derived from repeat customers, which signifies high levels of client satisfaction and trust in its technological solutions and project delivery capabilities.

• Global Market Leadership: Praj holds an approximate 10% market share in the global ethanol production market (excluding China), establishing it as a key international player in the bioenergy sector.

• Diversified Portfolio: The company offers a wide bouquet of solutions beyond bioenergy, including high purity water systems, critical process equipment for various industries, brewery plants, and wastewater treatment, reducing reliance on a single segment.

Praj's key differentiators are its integrated service model, strong intellectual property portfolio, and established global leadership, which foster high customer loyalty.

• Domestic Bioenergy Market: The Indian market is currently experiencing a slowdown in enquiries for new greenfield ethanol projects. This is attributed to the fact that capacity requirements for the EBP20 (Ethanol Blending Programme) have largely been met.

• International Bioenergy Market: In contrast to the domestic market, there are positive policy developments and increasing enquiries from international markets, including Indonesia, Panama, Argentina, Guatemala, Costa Rica, and Bolivia.

• Wastewater Treatment (ZLD): This segment is benefiting from favorable regulatory drivers that mandate stricter emissions compliance for manufacturing industries. This is creating new demand for Zero Liquid Discharge (ZLD) solutions.

• Emerging Tech Sectors: New opportunities are emerging from high-growth industries such as Battery manufacturing, Solar panel production, and Semiconductors, which require specialized water treatment and process solutions.

The domestic bioenergy segment is maturing, shifting focus to brownfield projects, while international markets and regulatory-driven demand in other segments present new avenues for growth.

• Historical Growth Rates: The company has a 3-year revenue CAGR of 11%, EBITDA CAGR of 16%, and PAT CAGR of 13%, indicating a solid long-term growth trajectory leading up to FY25.

• Order Book: As of Q3-FY26, the order book stands at a healthy INR 44,910 million. The order book has remained stable over the past year, ranging between INR 42,930 million and INR 44,910 million.

• Order Intake: Order intake for Q3-FY26 was INR 9,140 million. While this is lower than the INR 10,530 million intake in Q3-FY25, it shows continued business momentum.

• Segmental Contribution:

• Revenue (9M-FY26): Bioenergy is the largest contributor at 71%, followed by Engineering (18%) and High Purity (11%).

• Order Book (Q3-FY26): Bioenergy dominates with 77% of the order backlog.

• Order Intake (Q3-FY26): Order intake is more balanced, with Bioenergy at 45% and Engineering contributing a significant 42%.

• Geographical Mix: For Q3-FY26, the domestic market constitutes 66% of both revenue and the order backlog, with exports making up the remaining 34%.

While recent financial results have been subdued, the company maintains a robust order book and a balanced intake across segments, suggesting a stable underlying business pipeline.

• International Bioenergy Expansion: Positive policy shifts in several countries in Latin America and Southeast Asia create significant opportunities for exporting Praj's ethanol plant technology and services.

• Brownfield Projects: With the domestic greenfield cycle slowing, there is a rising number of enquiries for brownfield projects (expansions, modernizations) from existing customers in India.

• Future Fuels: The company is strategically positioned to capitalize on emerging "Future Fuels" such as Sustainable Aviation Fuel (SAF), Marine Biofuel, and Bio-Hydrogen.

• Carbon Capture, Utilization, and Storage (CCUS): Praj has secured a breakthrough order for CCUS skids from a global oil major, opening a new and potentially large market vertical.

• High-Tech Sectors: The Engineering and High Purity segments are seeing new opportunities from Data Centers, Battery manufacturing, Solar, and Semiconductor industries, which have specialized equipment and water system needs.

• Precision Fermentation: The company received its first contract under the National BioE3 policy for a precision fermentation project, signaling an entry into the advanced renewable chemicals and materials market.

Praj is actively pursuing multiple new growth avenues in future fuels, carbon capture, and high-tech industrial sectors to diversify its revenue streams beyond traditional bioenergy projects.

• Focus on Future Fuels: The company's R&D and business development efforts are increasingly directed towards next-generation biofuels like Sustainable Aviation Fuel (SAF), marine biofuels, and bio-hydrogen, positioning it for the next wave of energy transition.

• Developing GenX Capabilities: Praj is investing in its GenX business, which focuses on critical process equipment and modularization. The company is targeting high-potential areas like Data Centers and CCUS, though it acknowledges these investments have a longer gestation period.

• Expansion in Renewable Chemicals: Through its BioPrism® portfolio, Praj aims to expand into renewable chemicals and materials, leveraging its expertise in biotechnology and fermentation, as evidenced by its first precision fermentation contract.

The company's future strategy is centered on leveraging its core biotechnology expertise to expand into high-growth, technology-intensive areas like advanced biofuels and carbon capture.

• Recent Margin Contraction (Consolidated 9M-FY26):

• EBITDA Margin: Dropped significantly to 5.79% from 10.59% in the prior year period, a contraction of 480 basis points.

• PAT Margin: Fell to 0.53% from 7.56%, a decline of 703 basis points.

• Primary Drivers for Margin Impact in Q3-FY26:

• Revenue Mix: Margins were impacted by 1% due to a reduction in the share of higher-margin export revenue.

• Exceptional Item: The company recognized an incremental impact of INR 344 million due to revised labor codes, which increased liabilities for gratuity and leave benefits. This was a one-time charge that significantly impacted reported profitability.

• Historical Margin Trend:

• The company's consolidated EBITDA margin showed a positive trend, improving from 8.79% in FY22 to a peak of 11.19% in FY24, before declining to 10.06% in FY25. The 9M-FY26 performance marks a sharp deviation from this trend.

Recent profitability has been severely impacted by a combination of lower-margin domestic projects and a significant one-time expense related to new labor regulations.

• Slowdown in Core Market: The primary business, domestic bioenergy, is facing a slowdown in new project enquiries as initial blending targets are met. The company's growth is now more dependent on the less predictable brownfield and international markets.

• Long Gestation Investments: The company has acknowledged that its investments in the new-age GenX business have a long gestation period. This means capital is being deployed with a delayed and uncertain timeline for generating returns.

• Margin Volatility: Profit margins are sensitive to the geographical mix of revenues. An increased share of domestic business relative to exports can adversely impact overall margin profiles, as seen in the recent quarter.

• Policy and Regulatory Risk: A significant portion of the company's business, particularly in bioenergy and wastewater treatment, is influenced by government policies and regulations. Any adverse changes to these policies could impact demand.

Key risks include the maturation of the domestic ethanol market, the uncertain timeline for returns on new ventures, and margin pressure from shifts in the business mix.

• Strong Order Wins:

• GenX: Secured a significant breakthrough order for Carbon Capture, Utilization, and Storage (CCUS) skids from a global oil major.

• ZLD: Received a major order from a leading metals company for an integrated effluent treatment, water recycling, and ZLD solution.

• Brewery: Awarded a contract to set up the largest greenfield brewery in India.

• PHS (High Purity Solutions): Won its first contract for a precision fermentation project from Embio Ltd. under the National BioE3 policy.

• Order Book Composition:

• The total order backlog as of December 31, 2025, is INR 44,910 million.

• By segment, the backlog is composed of Bioenergy (77%), Engineering (18%), and High Purity (5%).

• By geography, the backlog is split between Domestic (66%) and Exports (34%).

The company has recently secured several marquee orders across all its business segments, demonstrating its competitive strength and success in diversifying its project pipeline.